265 results on '"McMullen, Julie R."'
Search Results
2. Research Priorities for Atrial Fibrillation in Australia: A Statement From the Australian Cardiovascular Alliance Clinical Arrhythmia Theme
3. Estrogen receptor alpha deficiency in cardiomyocytes reprograms the heart-derived extracellular vesicle proteome and induces obesity in female mice
4. IGF1–PI3K-induced physiological cardiac hypertrophy: Implications for new heart failure therapies, biomarkers, and predicting cardiotoxicity
5. Single–cell transcriptional and epigenetic mapping reveals cellular and molecular mechanisms driving non-ischemic cardiac fibrosis
6. Loss of the long non-coding RNA OIP5-AS1 exacerbates heart failure in a sex-specific manner
7. Prevention of Pathological Atrial Remodeling and Atrial Fibrillation: JACC State-of-the-Art Review
8. Distinct functional and molecular profiles between physiological and pathological atrial enlargement offer potential new therapeutic opportunities for atrial fibrillation.
9. Exercise training reveals micro-RNAs associated with improved cardiac function and electrophysiology in rats with heart failure after myocardial infarction
10. Deletion of the muscle enriched lncRNA Oip5os1 induces atrial dysfunction in male mice with diabetes
11. Editorial overview: Exercise-induced cardiac protection: Mechanisms and clinical implications
12. Clusterin is regulated by IGF1–PI3K signaling in the heart: implications for biomarker and drug target discovery, and cardiotoxicity
13. A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology
14. The IGF1-PI3K-Akt Signaling Pathway in Mediating Exercise-Induced Cardiac Hypertrophy and Protection
15. Adeno-Associated Virus Gene Therapy: Translational Progress and Future Prospects in the Treatment of Heart Failure
16. Standing up to the cardiometabolic consequences of hematological cancers
17. Cardiovascular magnetic resonance imaging for sequential assessment of cardiac fibrosis in mice: technical advancements and reverse translation.
18. PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart
19. Molecular Aspects of Exercise-induced Cardiac Remodeling
20. Expressing an inhibitor of PLCβ1b sustains contractile function following pressure overload
21. Lipids regulated by exercise and PI3K: potential role as biomarkers and therapeutic targets for cardiovascular disease
22. In Vivo Inhibition of miR-34a Modestly Limits Cardiac Enlargement and Fibrosis in a Mouse Model with Established Type 1 Diabetes-Induced Cardiomyopathy, but Does Not Improve Diastolic Function
23. Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure
24. Fine-Tuning Cardiac Insulin-Like Growth Factor 1 Receptor Signaling to Promote Health and Longevity
25. Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets
26. Author Correction: PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart
27. Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities
28. A Step-By-Step Method to Detect Neutralizing Antibodies Against AAV using a Colorimetric Cell-Based Assay
29. A protocol for rapid and parallel isolation of myocytes and non-myocytes from multiple mouse hearts
30. Tissue-specific expression of Cas9 has no impact on whole-body metabolism in four transgenic mouse lines
31. Overexpression of Heat Shock Protein 70 Improves Cardiac Remodeling and Survival in Protein Phosphatase 2A-Expressing Transgenic Mice with Chronic Heart Failure
32. Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload
33. Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling
34. Letʼs keep running… exercise, basic science and the knowledge gaps
35. Proteome characterisation of extracellular vesicles isolated from heart
36. FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K
37. Detailed metabolic phenotyping of four tissue specific Cas9 transgenic mouse lines
38. Old Drug, New Trick: Tilorone, a Broad-Spectrum Antiviral Drug as a Potential Anti-Fibrotic Therapeutic for the Diseased Heart
39. Loss of the Long Non-coding RNA OIP5-AS1 Exacerbates Heart Failure in a Sex-Specific Manner
40. Novel lipid species for detecting and predicting atrial fibrillation in patients with type 2 diabetes
41. Novel Lipid Species for Detecting and Predicting Atrial Fibrillation in Patients With Type 2 Diabetes
42. Andersen–Tawil Syndrome Is Associated With Impaired PIP2 Regulation of the Potassium Channel Kir2.1
43. Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes
44. Non-coding RNAs regulating cardiac muscle mass
45. Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling
46. Research Priorities for Atrial Fibrillation in Australia: A Statement From the Australian Cardiovascular Alliance Clinical Arrhythmia Theme.
47. CORP: Practical tools for improving experimental design and reporting of laboratory studies of cardiovascular physiology and metabolism
48. Noncoding RNAs regulating cardiac muscle mass
49. Multiple receptors converge on H2‐Q10 to regulate NK and γδT‐cell development
50. Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.